Lymphangioleiomyomatosis (LAM) Market - Top Companies and Manufacturers

Companies Dominating the Lymphangioleiomyomatosis (LAM) Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Zydus Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Ltd.
Apotex Inc.
Amneal Pharmaceuticals LLC.
Teva Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
AstraZeneca
AI Therapeutics, Inc.

Browse Key Market Insights with Data Illustration:

Lymphangioleiomyomatosis (LAM) Market Size & Share, Growth Analysis 2036

In the News

January 7, 2020: AI Therapeutics, a clinical-stage biopharmaceutical company, announced substantial progress on two of their programs - LAM-001, world’s first inhaled formulation of rapamycin that would be studied in clinical trials and LAM-004, which has finished a Phase 1 trial in patients having facial angiofibroma.
January 16, 2020: AI Therapeutics announced that their LAM-002 has received Fast Track status and Orphan Drug Designation from the U.S. FDA for Pivotal Trial Design of the treatment of follicular lymphoma.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of lymphangioleiomyomatosis is estimated at USD 133.86 million.

Lymphangioleiomyomatosis (LAM) Market size was over USD 128.91 million in 2023 and is anticipated to cross USD 237.13 million by 2036, growing at more than 4.8% CAGR during the forecast period i.e., between 2024-2036.

North America industry is likely to account for largest revenue share by 2036, attributed to factors such as high healthcare spending, a high rate of adoption of technologies, a rise in the prevalence of lifestyle-related disorders, and a promising pipeline.

The major players in the market are Pfizer Inc., Zydus Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Amneal Pharmaceuticals LLC., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., AstraZeneca, AI Therapeutics, Inc., and others.

Lymphangioleiomyomatosis (LAM) Market - Top Companies and Manufacturers

Companies Dominating the Lymphangioleiomyomatosis (LAM) Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the lymphangioleiomyomatosis market?

Why is the lymphangioleiomyomatosis sector gaining traction in near future?

Which region accounted for the largest lymphangioleiomyomatosis industry share?

Who are the major lymphangioleiomyomatosis players?